Applied Biosystems and Idaho Technology Enter Broad Patent Cross-Licensing Agreement
News Jan 27, 2010
Applied Biosystems LLC, part of Life Technologies Corporation, and Idaho Technology, Inc. have signed a cross-licensing agreement which covers a broad range of products including hardware, software and reagents.
“This agreement demonstrates both companies’ commitments to advancing quality research in the applied and life science fields. It also enables innovation in a more open environment that is good for business and ultimately benefits customers”
The agreement includes patents relating to real-time polymerase chain reaction methods and instrumentation, including the 5’ Nuclease process and the use of SYBR® Green I in PCR reactions.
“This agreement demonstrates both companies’ commitments to advancing quality research in the applied and life science fields. It also enables innovation in a more open environment that is good for business and ultimately benefits customers,” says Randy Rasmussen, President, Idaho Technology, Inc.
The intellectual property covered by this agreement has been instrumental in expanding applications in molecular biology and has been equally influential in each company’s success as a provider of solutions for DNA analysis.
The financial terms of the agreement will not be disclosed.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019
4th Annual Congress on Nanomedicine and Drug Delivery
Apr 04 - Apr 06, 2019